These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 21806373)
1. G-protein coupled receptor and kinase targets: advances in drug discovery from molecular to clinical. Spencer J Future Med Chem; 2011 Jul; 3(9):1097-100. PubMed ID: 21806373 [TBL] [Abstract][Full Text] [Related]
3. Adhesion G protein-coupled receptors: opportunities for drug discovery. Bassilana F; Nash M; Ludwig MG Nat Rev Drug Discov; 2019 Nov; 18(11):869-884. PubMed ID: 31462748 [TBL] [Abstract][Full Text] [Related]
4. Advancing the kinase field: new targets and second generation inhibitors. Laufer S; Bajorath J J Med Chem; 2015 Jan; 58(1):1. PubMed ID: 25490234 [No Abstract] [Full Text] [Related]
6. G-protein-coupled receptors signaling pathways in new antiplatelet drug development. Gurbel PA; Kuliopulos A; Tantry US Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):500-12. PubMed ID: 25633316 [TBL] [Abstract][Full Text] [Related]
7. Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis. Angiolini M Future Med Chem; 2011 Mar; 3(3):309-37. PubMed ID: 21446845 [TBL] [Abstract][Full Text] [Related]
8. Conference Report: update on screening methodologies. Bardera AI; Martin J Future Med Chem; 2009 May; 1(2):253-6. PubMed ID: 21425968 [TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of kinases and GPCRs: design principles and structural diversity. Lewis JA; Lebois EP; Lindsley CW Curr Opin Chem Biol; 2008 Jun; 12(3):269-80. PubMed ID: 18342020 [TBL] [Abstract][Full Text] [Related]
10. An emerging role for kinase screening in GPCR drug discovery. Osmond RI; Crouch MF; Dupriez VJ Curr Opin Mol Ther; 2010 Jun; 12(3):305-15. PubMed ID: 20521219 [TBL] [Abstract][Full Text] [Related]
11. Strategic Research Institute G-Protein-Coupled Receptors Drug Discovery World Summit. Felder CC Expert Opin Investig Drugs; 2004 Aug; 13(8):1071-4. PubMed ID: 15268643 [TBL] [Abstract][Full Text] [Related]
12. Editorial: GPCR-Targeted Drug Development. Sun L; Coy DH Curr Drug Targets; 2016; 17(5):486-7. PubMed ID: 26951060 [No Abstract] [Full Text] [Related]
13. Targeting cancer with small-molecular-weight kinase inhibitors. Fabbro D; Cowan-Jacob SW; Möbitz H; Martiny-Baron G Methods Mol Biol; 2012; 795():1-34. PubMed ID: 21960212 [TBL] [Abstract][Full Text] [Related]
14. Recent updates on GPCR biased agonism. Pupo AS; Duarte DA; Lima V; Teixeira LB; Parreiras-E-Silva LT; Costa-Neto CM Pharmacol Res; 2016 Oct; 112():49-57. PubMed ID: 26836887 [TBL] [Abstract][Full Text] [Related]
15. Designing multi-targeted agents: An emerging anticancer drug discovery paradigm. Fu RG; Sun Y; Sheng WB; Liao DF Eur J Med Chem; 2017 Aug; 136():195-211. PubMed ID: 28494256 [TBL] [Abstract][Full Text] [Related]
16. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target. Janero DR; Thakur GA Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124 [TBL] [Abstract][Full Text] [Related]
17. Screening for inducers of kinase degradation. Neckers L Chem Biol; 2003 Jul; 10(7):587-9. PubMed ID: 12890531 [TBL] [Abstract][Full Text] [Related]
18. G Protein-Coupled Receptor Heteromers. Gomes I; Ayoub MA; Fujita W; Jaeger WC; Pfleger KD; Devi LA Annu Rev Pharmacol Toxicol; 2016; 56():403-25. PubMed ID: 26514203 [TBL] [Abstract][Full Text] [Related]
19. Allosteric targeting of receptor tyrosine kinases. De Smet F; Christopoulos A; Carmeliet P Nat Biotechnol; 2014 Nov; 32(11):1113-20. PubMed ID: 25380447 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders. Lütjens R; Rocher JP Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]